BK CHANNEL MODULATION BY BETA SUBUNITS
BK CHANNEL MODULATION BY BETA SUBUNITS
批准号:
7536010
负责人:
Arthur Karlin
金额:
$35.22万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-03-05 至 2010-11-30
关键词:
AffectBiological AssayCalcium-Activated Potassium ChannelCardiovascular DiseasesCell surfaceCellsCharybdotoxinCrosslinkerCysteineEquilibriumFunctional disorderGoalsHypertensionIndividualKineticsLeadMapsMediatingMembraneMembrane PotentialsMolecularMono-SMutateNeuronsOxidantsPlayPredispositionReactionReaction TimeRegulationRelative (related person)RoleSideSmooth MuscleStrokeSuspension substanceSuspensionsTimeToxinWestern Blottingbasecrosslinkextracellulariberiotoxinlarge-conductance calcium-activated potassium channelsmutantnovelvoltage
中文摘要
BK通道是大电导、电压和钙激活的K通道(MAXI-K,SLO),由
由α亚基和最多4个β亚基组成的四聚体。Beta“!是四种类型的Beta亚基之一,可在
并调节电压和钙敏感性以及激活和失活的动力学
BK频道。这项提案的总体目标是确定
贝塔尔对阿尔法的调制,人们对此知之甚少。建议将它们的物理相互作用映射到
通道的关闭状态和打开状态,并确定这些状态的功能后果
互动。方法是将半胱氨酸(Cys)连续突变为四个残基,一次一个,在
每个跨膜片段(TM)的胞外侧翼区(TM),在α和β中。有7个TM
(SO-S6)在阿尔法和2个TM(TM1和TM2)在贝塔尔。所有突变体都将在HEK-293细胞中表达
对表情和功能进行筛选。所有一对功能突变都将在完整的细胞中用一种新的
无膜交联剂(0.5-1 nm跨度)和氧化剂(0.3 nm跨度),两者都是专用于
交联型半胱氨酸。完整细胞表面BK通道的交联度随时间的变化
交联剂浓度和反应时间将通过定量Western blotting来确定。相对的
将计算每对α半胱氨酸和贝塔半胱氨酸的速率常数,并将反映
这两个人。将确定显示为相邻的半胱氨酸的交联对的功能效应
经交联剂处理的细胞的电生理学内向外贴片。共价拴系法
如果αTMS正常,αSO-S6与βTM1或TM2的交联会深刻影响功能
在门控期间移动,可能会改变阿尔法-贝塔相互作用。函数变换的速率常数
将在通道的打开状态下以外向外贴片确定成对的Cys的交联度
与在闭合状态下确定的速率常数进行比较。两种状态下的速率常数的差异
将指示在选通期间,哪些阿尔法TM相对于Beta中的TM移动。BK渠道在以下方面发挥了重要作用
平滑肌收缩张力的调节和神经元功能及其病理生理学
与中风、高血压和心血管疾病有关。更好地理解分子
BK通道的调节机制将有助于改善治疗方法。
英文摘要
BK channels are large -conductance, voltage-and-Ca-activated K channels (maxi-K, slo), consisting of a
tetramer of alpha subunits and up to four beta subunits. Beta"!, one of four types of beta subunits, is found in
smooth muscle and modulates the voltage and Ca sensitivities and the kinetics of activation and deactivation
of BK channels. The overall goal of this proposal is the determination of the structural basis for the
modulation of alpha by betal, about which little is known. It is proposed to map their physical interactions in
both the closed state and open state of the channel and to determine the functional consequences of these
interactions. The approach is to mutate to cysteine (Cys) four consecutive residues, one at a time, in the
extracellular flanking region of each transmembrane segment (TM) in alpha and in beta. There are 7 TMs
(SO-S6) in alpha and 2 TMs (TM1 and TM2) in betal. All mutants will be expressed in HEK-293 cells and
screened for expression and function. All pairs of functional mutants will be probed in intact cells with a novel
membrane-impermeant crosslinker (0.5 -1 nm span) and an oxidizing agent (0.3 nm span), both specific for
crosslinking Cys. The extents of crosslinking of BK channel on the cell surface of intact cells with varying
crosslinker concentrations and reaction times will be determined by quantitative Western blotting. Relative
rate constants of each pair of an alpha Cys and a betal Cys will be calculated and will reflect the proximity of
the pair. The functional effects of crosslinking pairs of Cys shown to be neighbors will be determined
electrophysiologically in inside-out patches from cells treated with crosslinkers. The tethering by covalent
crosslinking of alpha SO-S6 to betal TM1 or TM2 should profoundly affect function if the alpha TMs normally
move during gating, possibly altering alpha -beta interactions. The rate constants for function-altering
crosslinking of pairs of Cys will be determined in the open state of the channel in outside-out patches and
compared to the rate constants determined in the closed state. Differences in rate constants in the two states
will indicate which TMs of alpha move relative to TMs in beta during gating. BK channels play a major role in
the regulation of contractile tone in smooth muscle and neuronal function, and their pathophysiology is
implicated in stroke, hypertension, and cardiovascular disease. Greater understanding of the molecular
mechanisms of BK channel regulation will lead to improvedtherapeutics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BK CHANNEL MODULATION BY BETA SUBUNITS
-
批准号:8040753
-
项目类别:
-
资助金额:$35.09万
-
财政年份:2007
-
负责人:Arthur Karlin
-
依托单位:
BK CHANNEL MODULATION BY BETA SUBUNITS
-
批准号:8415907
-
项目类别:
-
资助金额:$33.78万
-
财政年份:2007
-
负责人:Arthur Karlin
-
依托单位:
BK CHANNEL MODULATION BY BETA SUBUNITS
-
批准号:8601759
-
项目类别:
-
资助金额:$34.65万
-
财政年份:2007
-
负责人:Arthur Karlin
-
依托单位:
BK CHANNEL MODULATION BY BETA SUBUNITS
-
批准号:8213464
-
项目类别:
-
资助金额:$35.0万
-
财政年份:2007
-
负责人:Arthur Karlin
-
依托单位:
BK CHANNEL MODULATION BY BETA SUBUNITS
-
批准号:7208171
-
项目类别:
-
资助金额:$35.22万
-
财政年份:2007
-
负责人:Arthur Karlin
-
依托单位:
Allosteric Modulation of Cardiovascular Ion Channels
-
批准号:8133509
-
项目类别:
-
资助金额:$104.95万
-
财政年份:2007
-
负责人:Arthur Karlin
-
依托单位:
Allosteric Modulation of Cardiovascular Ion Channels
-
批准号:7186069
-
项目类别:
-
资助金额:$168.89万
-
财政年份:2007
-
负责人:Arthur Karlin
-
依托单位:
BK CHANNEL MODULATION BY BETA SUBUNITS
-
批准号:7369746
-
项目类别:
-
资助金额:$35.22万
-
财政年份:2007
-
负责人:Arthur Karlin
-
依托单位:
Allosteric Modulation of Cardiovascular Ion Channels
-
批准号:7930553
-
项目类别:
-
资助金额:$122.42万
-
财政年份:2007
-
负责人:Arthur Karlin
-
依托单位:
ALLOSTERIC SITE STRUCTURES OF CARDIOVASCULAR CHANNELS
-
批准号:7215384
-
项目类别:
-
资助金额:$39.12万
-
财政年份:2007
-
负责人:Arthur Karlin
-
依托单位:
ADMINISTRATIVE CORE
-
批准号:7215388
-
项目类别:
-
资助金额:$8.41万
-
财政年份:2007
-
负责人:Arthur Karlin
-
依托单位:
BK CHANNEL MODULATION BY BETA SUBUNITS
-
批准号:7737351
-
项目类别:
-
资助金额:$34.87万
-
财政年份:2007
-
负责人:Arthur Karlin
-
依托单位:
Allosteric Modulation of Cardiovascular Ion Channels
-
批准号:7667694
-
项目类别:
-
资助金额:$168.89万
-
财政年份:2007
-
负责人:Arthur Karlin
-
依托单位:
Allosteric Modulation of Cardiovascular Ion Channels
-
批准号:7488904
-
项目类别:
-
资助金额:$165.51万
-
财政年份:2007
-
负责人:Arthur Karlin
-
依托单位:
MEMBRANE RECEPTORS AND TRANSPORT PROTEINS
-
批准号:2260436
-
项目类别:
-
资助金额:$19.7万
-
财政年份:1985
-
负责人:Arthur Karlin
-
依托单位:
MEMBRANE RECEPTORS AND TRANSPORT PROTEINS
-
批准号:3543979
-
项目类别:
-
资助金额:$17.08万
-
财政年份:1985
-
负责人:Arthur Karlin
-
依托单位:
MEMBRANE RECEPTORS AND TRANSPORT PROTEINS
-
批准号:2260438
-
项目类别:
-
资助金额:$2.79万
-
财政年份:1985
-
负责人:Arthur Karlin
-
依托单位:
MEMBRANE RECEPTORS AND TRANSPORT PROTEINS
-
批准号:2260435
-
项目类别:
-
资助金额:$18.93万
-
财政年份:1985
-
负责人:Arthur Karlin
-
依托单位:
MEMBRANE RECEPTORS AND TRANSPORT PROTEINS
-
批准号:3543981
-
项目类别:
-
资助金额:$15.24万
-
财政年份:1985
-
负责人:Arthur Karlin
-
依托单位:
MEMBRANE RECEPTORS AND TRANSPORT PROTEINS
-
批准号:3543982
-
项目类别:
-
资助金额:$11.29万
-
财政年份:1985
-
负责人:Arthur Karlin
-
依托单位:
海外基金